Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 377-381 , July 2009

Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis

  • Vanessa K. de Sá, B.S.

      Affiliations

    • Laboratory of Medical Investigation–LIM55 Medical School, Urology Department, São Paulo University, São Paulo, Brazil
    • ,
  • Flávio C. Canavez, Ph.D.

      Affiliations

    • Genoa Biotechnology, São Paulo, Brazil
    • ,
  • Iran A. Silva, B.S.

      Affiliations

    • Laboratory of Medical Investigation–LIM55 Medical School, Urology Department, São Paulo University, São Paulo, Brazil
    • ,
  • Miguel Srougi, M.D., Ph.D.

      Affiliations

    • Laboratory of Medical Investigation–LIM55 Medical School, Urology Department, São Paulo University, São Paulo, Brazil
    • ,
  • Katia R.M. Leite, M.D., Ph.D.

      Affiliations

    • Laboratory of Medical Investigation–LIM55 Medical School, Urology Department, São Paulo University, São Paulo, Brazil
    • Genoa Biotechnology, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-11-3069 8080; fax: +55-11-3231 2249

Received 28 January 2008 ,Revised 11 April 2008 ,Accepted 17 April 2008.

References 

  1. American Cancer Society. Cancer facts and figures, 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf[Accessed September 2, 2007]
  2. Graefen M, Karakiewicz PI, Cagiannos I, et al. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urol Oncol. 2002;7:141–146
  3. Stern R. Devising a pathway for hyaluronan catabolism: Are we there yet?. Glycobiology. 2003;12:105–115
  4. Delpech B, Girard N, Bertrand P, et al. Hyaluronan: Fundamental principles and applications in cancer. J Intern Med. 1997;242:41–48
  5. Turley EA, Noble PW, Bourguignon LYW. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277:4589–4592
  6. Herrlich P, Morrison H, Sleeman J, et al. CD44 acts both as a growth and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann NY Acad Sci. 2000;910:106–118
  7. Posey T, Soloway MS, Ekici S, et al. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. Cancer Res. 2003;63:2638–2644
  8. Pirinen R, Tammi R, Tammi M, et al. Prognostic value of hyaluronan expression in non-small cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer. 2001;95:12–17
  9. Ropponen K, Tammi M, Parkkinen J, et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998;58:342–347
  10. Hobarth K, Maier U, Marberger M. Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase. Eur Urol. 1992;21:206–210
  11. Rein DT, Roehrig K, Schondorf T, et al. Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumor progression and metastasis. J Cancer Res Clin Oncol 203;129:161–4.
  12. Lokeshwar VB, Obek C, Soloway MS, et al. Tumor associated hyaluronic acid: A new sensitive and specific urine marker for bladder cancer. Cancer Res. 1998;58:31–41
  13. Lokeshwar VB, Rubinowicz D, Schroeder GL, et al. Stromal and epithelial expression of tumor markers hyaluronic acid and hyaluronidase in prostate cancer. J Biol Chem. 1998;276:11922–11932
  14. Markovic-Housley Z, Miglierini G, Soldatova L, et al. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure. 2000;8:1025–1035
  15. Halici M, Karaoglu S, Canoz O, et al. Sodium hyaluronate regulating angiogenesis during Achilles tendon healing. Knee Surg Sports Traumatol Arthrosc. 2004;12:562–567
  16. Harada H, Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem. 2007;282:5597–5607
  17. Chao KL, Muthukumar L, Herzberg O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry. 2007;46:6911–6920
  18. Lokeshwar VB, Schroeder GL, Carey RI, et al. Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem. 2002;277:33654–33663
  19. Bertrand P, Courel MN, Maingonnat C, et al. Expression of HYAL2 mRNA, hyaluronan, and hyaluronidase in B-cell non-Hodgkin lymphoma (Relationship with tumor aggressiveness). Int J Cancer. 2006;113:207–212
  20. Li R, Todd NW, Qiu Q, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res. 2007;13:482–487
  21. Lexander H, Franzén B, Hirschberg D, et al. Differential protein expression in anatomical zones of the prostate. Proteomics. 2005;5:2570–2576

PII: S1078-1439(08)00111-7

doi: 10.1016/j.urolonc.2008.04.013

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 377-381 , July 2009

Article Tools

* Image Usage & Resolution